TGen, Avery Therapeutics partnership studies engineered heart tissue's mechanism of action

(The Translational Genomics Research Institute) Avery Therapeutics Inc. of Tucson has developed an engineered heart tissue, a lab-grown cardiac membrane that can help heal the heart, either following a heart attack or as a result of progressive heart disease. The heart tissue, called MyCardia ™ , could revolutionize the treatment of cardiovascular disease, and someday might be applied to other failing organs. To better understand how MyCardia works -- at the infinitesimally small molecular level -- Avery has partnered with TGen.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news